GLP1R and diabetes mellitus: The management of diabetes and its long-term complications has significantly improved over the past decade with the introduction of new therapeutic interventions aimed at optimizing blood glucose control and weight management, such as sodium-glucose co-transporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs), alongside the promotion of healthier lifestyle.